School of Health and Medical Sciences Department of Obstetrics and Gynaecology Department of Urology Örebro University Hospital, Örebro, Sweden.
Acta Obstet Gynecol Scand. 2013 May;92(5):555-61. doi: 10.1111/j.1600-0412.2012.01481.x. Epub 2012 Nov 1.
Objective. To validate the Swedish versions of the Incontinence Impact Questionnaire (IIQ-7) and Urogenital Distress Inventory (UDI-6). Design and setting. Prospective study, university hospital. Population and method. We analyzed reliability, validity, and responsiveness in a clinical sample of 96 women with urinary incontinence. Main outcome measures. Construct and criterion validity, reliability via test-retest and internal consistency. Responsiveness via calculation of effect size. Result. Test-retest reliability ranged from moderate to almost perfect. Cronbach's alpha was 0.39 (UDI-6) and 0.83 (IIQ-7). Effect size calculation of change after treatment demonstrated good responsiveness. The effect size at six months was moderate in the Stress Urinary Incontinence group and small in the Urge Urinary Incontinence + Mixed Urinary Incontinence group. There was a moderate to strong correlation between UDI-6 and IIQ-7 and treatment satisfaction at six, 12, and 24 months for both groups. Conclusion. The UDI-6 scale did not produce the same solid result in the psychometric analysis as the IIQ-7 scale, but these newly translated Swedish forms of UDI-6 and IIQ-7 show good responsiveness and are easy to administer and to fill out.
目的。验证《尿失禁影响问卷》(IIQ-7)和《女性尿失禁生活质量问卷》(UDI-6)的瑞典语版本。
设计和设置。前瞻性研究,大学医院。
人群和方法。我们分析了 96 例尿失禁女性的临床样本的可靠性、有效性和反应性。
主要结局指标。构建和标准有效性、通过测试-重测和内部一致性的可靠性、通过计算效应量的反应性。
结果。测试-重测可靠性从中等到几乎完美不等。UDI-6 的 Cronbach's alpha 为 0.39,IIQ-7 的 Cronbach's alpha 为 0.83。治疗后变化的效应量计算表明具有良好的反应性。在压力性尿失禁组,6 个月时的效应量为中度,在急迫性尿失禁+混合性尿失禁组,效应量为小。在治疗后 6、12 和 24 个月,UDI-6 和 IIQ-7 与两组的治疗满意度之间存在中度到高度相关性。
结论。UDI-6 量表在心理测量分析中没有产生与 IIQ-7 量表相同的可靠结果,但这些新翻译的瑞典语形式的 UDI-6 和 IIQ-7 显示出良好的反应性,易于管理和填写。